Overview

A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial will be studying how well Apatinib working in patients with liver cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Collaborator:
Eighty-One Hospital of People's Liberation Army
Treatments:
Apatinib